title: A two-year experience with a rapid access, self-sealing, polycarbonate urethane nanofiber vascular access graft for hemodialysis.
abstract: OBJECTIVE
  Evaluating the safety and efficacy of the AVflo™ graft in terms of patency and complications (early and late) over 2 years.
  
  
  METHODS
  Twelve end-stage renal disease (ESRD) patients (age: mean 68.5 ± 10 years) were followed up for a mean period of 946 ± 570 days after receiving an implantation of the graft for HD. The grafts were implanted at the lower arm (loop configuration), upper arm (straight configuration) and the thigh (loop configuration). First dialysis was performed at day 7 (3-21) following implantation.
  
  
  CONCLUSIONS
  After a mean follow up of 24 months, the primary patency was 56% and the secondary patency was 82%. In this group, AVflo™ shows similar if not superior efficacy and safety to that of available grafts in terms of safety, complications, and long-term patency.
authors.affiliation: Division of Kidney Transplantation, Cà Granda Foundation I.R.C.C.S., Ospedale Maggiore-Policlinico, Milan - Italy.|Department of Clinical Sciences and Community Health, University of Milan, Milan - Italy.
authors.forename: Mariano
authors.initials: M
authors.lastname: Ferraresso
authors.affiliation: Department of Clinical Sciences and Community Health, University of Milan, Milan - Italy.
authors.forename: Ettore M
authors.initials: EM
authors.lastname: Bortolani
authors.affiliation: Nicast Limited, Lod - Israel.
authors.forename: Gildor
authors.initials: G
authors.lastname: Amnon
mesh_terms: D000368:Aged; D001166:Arteriovenous Shunt, Surgical / Q000009:adverse effects / Q000295:instrumentation*; D001807:Blood Vessel Prosthesis; D019917:Blood Vessel Prosthesis Implantation / Q000009:adverse effects / Q000295:instrumentation*; D005260:Female; D006083:Graft Occlusion, Vascular / Q000209:etiology / Q000503:physiopathology; D006801:Humans; D053208:Kaplan-Meier Estimate; D007676:Kidney Failure, Chronic / Q000175:diagnosis / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D057139:Nanofibers; D011076:Polycarboxylate Cement / Q000737:chemistry*; D011474:Prosthesis Design; D006435:Renal Dialysis; D013848:Thigh / Q000098:blood supply*; D013997:Time Factors; D016896:Treatment Outcome; D034941:Upper Extremity / Q000098:blood supply*; D014654:Vascular Patency
chemical_list: D011076:Polycarboxylate Cement; C005506:polycarbonate